AlphaHelix Molecular Diagnostics AB (4MB) Financial Statements
AlphaHelix Molecular Diagnostics AB Financial Overview
AlphaHelix Molecular Diagnostics AB's market cap is currently $1.31M. The company's EPS TTM is ―; its P/E ratio is 1.61; AlphaHelix Molecular Diagnostics AB has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 21 | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | $ 17.88M | $ 9.14M | $ 7.49M | $ 8.03M | $ 10.66M |
| Operating Income | $ 5.26M | $ 1.55M | $ -873.83K | $ -1.18M | $ -597.58K |
| EBITDA | $ 6.52M | $ 1.76M | $ -613.60K | $ -648.02K | $ -153.10K |
| Net Income | $ 5.16M | $ 1.51M | $ -983.25K | $ -1.37M | $ -766.45K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 32.06M | $ 9.90M | $ 8.80M | $ 10.01M | $ 10.48M |
| Total Debt | $ 900.00K | $ 1.20M | $ 2.33M | $ 2.32M | $ 2.18M |
| Net Debt | $ -4.96M | $ -220.10K | $ 1.92M | $ 2.03M | $ 2.05M |
| Total Liabilities | $ 9.95M | $ 6.90M | $ 7.31M | $ 7.54M | $ 6.64M |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ 1.63M | $ 1.84M | $ 69.02K | $ 12.68K | $ -785.95K |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD
